Cargando…
Indacaterol therapy in moderate-to-severe chronic obstructive pulmonary disease: findings from a single-center primary care cohort
BACKGROUND: Once-daily long-acting β(2)-agonists (LABAs) are an important treatment option, either alone or in combination with other inhaled long-acting bronchodilators in the management of chronic obstructive pulmonary disease (COPD). AIMS/OBJECTIVES: To audit the effectiveness of indacaterol as m...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3862397/ https://www.ncbi.nlm.nih.gov/pubmed/24353411 http://dx.doi.org/10.2147/COPD.S53707 |